Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.3748
-0.0067 (-1.76%)
At close: Mar 26, 2026, 4:00 PM EDT
0.3671
-0.0077 (-2.05%)
After-hours: Mar 26, 2026, 7:58 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $87.96 million as of March 26, 2026. Its market cap has decreased by -68.18% in one year.
Market Cap
87.96M
Enterprise Value
158.80M
1-Year Change
-68.18%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $87.96M, a decrease of -91.16%. That is a compound annual growth rate of -28.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 89.54M | -87.52% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 96.50M |
| Seer, Inc. | 95.07M |
| Spruce Biosciences | 94.82M |
| Reviva Pharmaceuticals Holdings | 91.59M |
| Vivani Medical | 91.42M |
| Seres Therapeutics | 89.44M |
| Fortress Biotech | 89.39M |
| Anixa Biosciences | 88.18M |